Pearson syndrome is a rare, serious mitochondrial disorder that primarily affects the bone marrow and pancreas. It strikes in infancy, typically causing severe anemia that requires repeated blood transfusions alongside digestive problems from a malfunctioning pancreas. With an estimated prevalence of about 1 in 1,000,000 and fewer than 150 cases reported worldwide, it is one of the rarest inherited metabolic diseases known.
How Mitochondrial DNA Deletions Cause the Disease
Every cell in your body contains mitochondria, tiny structures that convert energy from food into a form cells can actually use. This energy conversion process, called oxidative phosphorylation, depends on instructions encoded in mitochondrial DNA (mtDNA), which is separate from the DNA in the cell’s nucleus.
Pearson syndrome results from large deletions in mtDNA, ranging from 1,000 to 10,000 nucleotides (the building blocks of DNA). The most common deletion, found in about 20% of affected individuals, removes exactly 4,997 nucleotides. These missing segments wipe out genes essential for energy production, leaving cells unable to generate enough power to function properly. The organs hit hardest are those with the highest energy demands: bone marrow, the pancreas, the liver, and the kidneys.
One important concept is heteroplasmy. Not every mitochondrion in a person’s cells carries the deletion. The ratio of normal to deleted mtDNA varies between tissues and even between individual cells, which partly explains why the disease affects some organs more severely than others and why symptoms can differ from one child to the next.
Bone Marrow Failure and Severe Anemia
The hallmark of Pearson syndrome is transfusion-dependent macrocytic anemia, meaning the bone marrow produces red blood cells that are too large and too few. Under a microscope, the bone marrow of affected children shows three characteristic features: low cellularity (fewer blood-forming cells than normal), prominent vacuoles (fluid-filled pockets) inside the blood cell precursors, and ringed sideroblasts, which are developing red blood cells with iron deposits circling the nucleus instead of being properly incorporated into hemoglobin.
Because the bone marrow cannot keep up with the body’s need for red blood cells, children with Pearson syndrome often require frequent blood transfusions starting in the first months of life. White blood cell and platelet counts can also be affected, raising the risk of infections and bleeding problems.
Pancreatic and Digestive Problems
The second major feature is exocrine pancreatic insufficiency. The pancreas normally releases digestive enzymes into the small intestine to break down fats (lipase), carbohydrates (amylase), and proteins (protease and elastase). In Pearson syndrome, the energy-starved pancreatic cells fail to produce enough of these enzymes.
The practical result is malabsorption. Nutrients, especially fats, pass through the gut without being properly digested, leading to greasy, foul-smelling stools, poor weight gain, and nutritional deficiencies. Doctors can confirm the problem with a stool test measuring elastase levels: little or no elastase in the stool points to pancreatic insufficiency. Pancreatic enzyme replacement therapy, taken with meals, helps children absorb more nutrients from food.
Other Organ Involvement
Because mitochondria exist in virtually every cell, Pearson syndrome can affect organs beyond the marrow and pancreas. Lactic acidosis is common and potentially life-threatening. It occurs when cells, unable to complete normal energy production, generate excess lactic acid that builds up in the blood. Episodes of metabolic crisis from severe lactic acidosis are one of the leading causes of death in affected infants.
The liver can develop steatosis (fat accumulation) and progressive dysfunction. Kidney problems also occur. Together, liver failure and uncontrolled lactic acidosis account for the majority of fatal outcomes. About half of children with Pearson syndrome die in infancy or early childhood from these complications or from overwhelming infections (sepsis), which their compromised immune systems struggle to fight.
How Pearson Syndrome Is Diagnosed
Diagnosis usually begins when an infant presents with unexplained, severe anemia that doesn’t respond to standard treatments. A bone marrow biopsy revealing vacuolized precursors and ringed sideroblasts raises suspicion. The combination of bone marrow failure plus pancreatic insufficiency in a young child is highly suggestive.
Confirmation requires genetic testing that detects large-scale deletions in mitochondrial DNA. Because the proportion of deleted mtDNA can vary between tissues, testing blood alone may sometimes underestimate the deletion load. Elevated blood lactate levels and signs of pancreatic insufficiency on stool testing support the diagnosis.
Treatment and Daily Management
There is no cure for Pearson syndrome. Management focuses on supporting the organs that are failing. The core treatments include frequent blood transfusions to compensate for the bone marrow’s inability to produce enough red blood cells, pancreatic enzyme supplements taken with every meal to improve fat and nutrient absorption, and careful monitoring for metabolic crises. Infections must be treated promptly and aggressively, since even routine childhood illnesses can spiral quickly in these children.
For children who survive infancy with appropriate supportive care, bone marrow function and pancreatic function can sometimes improve. The deleted mitochondrial DNA in blood-forming cells may gradually be outcompeted by cells carrying normal mtDNA, leading to partial or even complete recovery of blood counts.
Progression to Kearns-Sayre Syndrome
Children who survive the early, most dangerous years of Pearson syndrome face a different challenge. The same large mtDNA deletions that cause Pearson syndrome also cause Kearns-Sayre syndrome, a condition that primarily affects the muscles, eyes, and nervous system. Survivors of Pearson syndrome commonly develop features of Kearns-Sayre syndrome, typically beginning around age 3 or later. These features include drooping eyelids, difficulty moving the eyes, muscle weakness, hearing loss, and heart conduction problems.
Some children also develop features of Leigh syndrome, a severe neurological condition affecting the brainstem and deep brain structures. The transition happens because as blood cells with deleted mtDNA are replaced, the deletion persists in non-dividing tissues like muscle and nerve cells, where its effects accumulate over time. In essence, the disease shifts its target from the bone marrow to the nervous system and muscles as the child grows.